- Home
- / Smith & Nephew
- / Revenue
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Annual Revenue ($)
Smith & Nephew revenue was $5.21 b in FY, 2021
| FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | |
|---|---|---|---|---|
| Revenue | $4.9 b | $5.14 b | $4.56 b | $5.21 b |
Revenue Breakdown
Business Segment
Smith & Nephew revenue breakdown by business segment: 8.0% from SPORTS MEDICINE JOINT REPAIR, 5.7% from ARTHROSCOPIC ENABLING TECHNOLOGIES, 5.5% from TRAUMA & EXTREMITIES, 8.4% from KNEE IMPLANTS, 5.9% from HIP IMPLANTS, 7.0% from ADVANCED WOUND CARE, 20.7% from ORTHOPAEDICS, 14.4% from ADVANCED WOUND MANAGEMENT, 15.0% from SPORTS MEDICINE & ENT and 9.5% from Other
| FY, 2018 | FY, 2021 | FY, 2020 | FY, 2019 | |
|---|---|---|---|---|
| RECONSTRUCTION | $68 k | $79 k | ||
| SPORTS MEDICINE JOINT REPAIR | $697 k | $839 k | $710 k | $794 k |
| ARTHROSCOPIC ENABLING TECHNOLOGIES | $600 k | $590 k | $517 k | $591 k |
| TRAUMA & EXTREMITIES | $493 k | $576 k | $460 k | $488 k |
| KNEE IMPLANTS | $1.02 m | $876 k | $822 k | $1.04 m |
| HIP IMPLANTS | $613 k | $612 k | $567 k | $613 k |
| ADVANCED WOUND CARE | $740 k | $731 k | $647 k | $714 k |
| ADVANCED WOUND BIOACTIVES | $320 k | $496 k | $431 k | $424 k |
| ADVANCED WOUND DEVICES | $215 k | $269 k | $232 k | $242 k |
| EAR, NOSE AND THROAT | $131 k | $106 k | $151 k | |
| ORTHOPAEDICS | $2.16 m | |||
| ADVANCED WOUND MANAGEMENT | $1.5 m | |||
| SPORTS MEDICINE & ENT | $1.56 m | |||
| OTHER RECONSTRUCTION | $92 k | |||
| OTHER SURGICAL BUSINESSES | $209 k |
Need Data?
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.